Orencia approved by FDA for new indication — graft vs host disease; Sosei and Twist announce antibody discovery deal
For the first time, doctors will have a drug to combat acute graft-versus-host disease — a dangerous side effect of stem cell transplants in which donor …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
